Veracyte | VCYT - Текущие активы





Текущие активы Изменить Дата
Agenus USD 133.44M 514K 2025-12
Agilent USD 4.62B 21M 2025-12
Anika Therapeutics USD 103.36M 1.77M 2025-12
Arrowhead Research USD 1.17B 223.75M 2025-12
Bruker USD 2.21B 138.1M 2025-12
Heron Therapeutics USD 238.07M 8.67M 2025-12
Illumina USD 3.29B 493M 2025-12
Intrexon USD 23.72M 45.04M 2024-06
Karyopharm Therapeutics USD 103.15M 13.4M 2025-12
Laboratory Of America USD 4.02B 58.3M 2025-12
Ligand Pharmaceuticals USD 832.27M 78.35M 2025-12
Myriad Genetics USD 332.6M 12.2M 2025-12
Rigel Pharmaceuticals USD 214.93M 39.53M 2025-09
Roche Holding CHF 38.73B 3.03B 2025-12
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Siemens EUR 67.91B 3.2B 2025-12
Sonic Healthcare AUD 2.3B 52.76M 2024-12
Thermo Fisher Scientific USD 22.32B 6.39B 2026-03
Veracyte USD 488.38M 39.15M 2025-12
Waters USD 1.99B 69.86M 2025-12